Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting

SIMPLE SUMMARY: In the past decade, several novel renal neoplasms characterized by mutations in the tuberous sclerosis complex (TSC) or mechanistic target of rapamycin (mTOR) pathway genes in both the sporadic and germline settings have been described. Herein, we review these entities, highlighting...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapur, Payal, Brugarolas, James, Trpkov, Kiril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452688/
https://www.ncbi.nlm.nih.gov/pubmed/37627070
http://dx.doi.org/10.3390/cancers15164043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452688/
https://www.ncbi.nlm.nih.gov/pubmed/37627070
http://dx.doi.org/10.3390/cancers15164043

Ejemplares similares